Introduction: The Challenge of Poorly Soluble APIs The pharmaceutical industry faces a critical challenge: approximately 70-90% of drug candidates in […]
Introduction In modern parenteral drug delivery, excipient quality plays a decisive role in how a formulation behaves throughout its lifecycle—from
High-Purity PLA Grades for Parenteral Use — Product Overview Read More »
Summary of This Article Introduction ResolveMass Laboratories Inc. supplies high-quality Standard PLGA Grades, such as 50:50, 65:35, 75:25, and 85:15
INTRODUCTION: PLGA Microsphere Formulation is the most reliable strategy for delivering highly potent APIs (HPAPIs) because it reduces systemic toxicity,
Formulating Highly Potent APIs Using PLGA Poly(lactic-co-glycolic acid) Microspheres Read More »
Summary (Key Highlights) Introduction: Why GMP PLGA Requirements Are Critical for Injectable Drug Products Ensuring compliance with GMP PLGA requirements
Summary Introduction Ensuring thorough PLGA Supplier Qualification is a crucial requirement for maintaining compliance, reproducibility, and consistent clinical performance in
INTRODUCTION Selecting PLGA for peptide, protein, and nucleic acid delivery requires choosing the right polymer chemistry, molecular weight, and end-group
Selecting PLGA for Peptide, Protein, and Nucleic Acid (mRNA/siRNA) Delivery Read More »
Introduction PLGA Characterization Methods are essential to ensure the performance, purity, safety, and reproducibility of Poly(lactic-co-glycolic acid)—one of the most
INTRODUCTION At ResolveMass Laboratories Inc., we understand that a robust PLGA Degradation Profile is fundamental to the success of any
INTRODUCTION PLGA Microsphere Formulation is the cornerstone of controlled-release drug delivery because particle engineering enables precise control over degradation, release
